Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Search Science Hub
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
Congress on Cardiovascular, Kidney and Metabolic Outcomes
Prevalence and effect of semaglutide on non-alcoholic steatohepatitis in people with obesity with and without type 2 diabetes: analyses from the STEP 1 and 2 trials using SomaSignal tests
Congress on Cardiovascular, Kidney and Metabolic Outcomes